The New Instructions to Authors for the Reporting of Steroid Hormone Measurements Editorial 12 November 2014 Pages: 357 - 357
FASNating Targets of Metformin in Breast Cancer Stem-Like Cells Elizabeth A. WellbergSteven M. Anderson Editorial 30 August 2014 Pages: 358 - 362
Modulation of Sodium Iodide Symporter in Thyroid Cancer Aparna LakshmananDaniel ScarberrySissy M. Jhiang Review 19 September 2014 Pages: 363 - 373
Metformin-Induced Killing of Triple-Negative Breast Cancer Cells Is Mediated by Reduction in Fatty Acid Synthase via miRNA-193b Reema S. Wahdan-AlaswadDawn R. CochraneJennifer K. Richer Original Paper 12 September 2014 Pages: 374 - 389
The G Protein-Coupled Estrogen Receptor-1, GPER-1, Promotes Fibrillogenesis via a Shc-Dependent Pathway Resulting in Anchorage-Independent Growth Hilary T. MagruderJeffrey A. QuinnEdward J. Filardo Original Paper 06 August 2014 Pages: 390 - 404
Elevated APOBEC3B Correlates with Poor Outcomes for Estrogen-Receptor-Positive Breast Cancers Anieta M. SieuwertsScooter WillisJohn W. M. Martens Original Paper Open access 15 August 2014 Pages: 405 - 413
RhoC Upregulation Is Correlated with Reduced E-cadherin in Human Breast Cancer Specimens After Chemotherapy and in Human Breast Cancer MCF-7 Cells Hirotoshi KawataTomoko KamiakitoAkira Tanaka Original Paper 15 August 2014 Pages: 414 - 423
Erratum to: The Combination of Insulin-Like Growth Factor Receptor 1 (IGF1R) Antibody Cixutumumab and Mitotane as a First-Line Therapy for Patients with Recurrent/Metastatic Adrenocortical Carcinoma: a Multi-institutional NCI-Sponsored Trial Antonio M. LerarioFrancis P. WordenGary D. Hammer Erratum 06 September 2014 Pages: 424 - 424
